News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
157,127 Results
Type
Article (7601)
Company Profile (26)
Press Release (149499)
Multimedia
Podcasts (5)
Webinars (4)
Section
Business (53638)
Career Advice (358)
Deals (9479)
Drug Delivery (9)
Drug Development (19944)
Employer Resources (18)
FDA (3737)
Job Trends (3919)
News (85134)
Policy (6566)
Tag
2027 Biotech Bay Standard (2)
2027 Genetown Elite (1)
Academia (499)
Accelerated approval (9)
Adcomms (6)
Allergies (44)
Alliances (7419)
ALS (48)
Alzheimer's disease (368)
Antibody-drug conjugate (ADC) (83)
Approvals (3946)
Artificial intelligence (82)
Autoimmune disease (36)
Automation (3)
Bankruptcy (55)
Best Places to Work (3331)
BIOSECURE Act (4)
Biosimilars (58)
Biotechnology (18)
Bladder cancer (56)
Brain cancer (17)
Breast cancer (206)
Cancer (1413)
Cardiovascular disease (127)
Career advice (333)
Career pathing (5)
CAR-T (47)
CDC (22)
Cell therapy (129)
Cervical cancer (14)
Clinical research (18213)
Collaboration (267)
Company closure (1)
Compensation (195)
Complete response letters (11)
COVID-19 (649)
CRISPR (15)
C-suite (109)
Cystic fibrosis (30)
Data (2139)
Depression (41)
Diabetes (163)
Diagnostics (1439)
Digital health (8)
Diversity (1)
Diversity, equity & inclusion (6)
Drug discovery (31)
Drug pricing (31)
Drug shortages (1)
Duchenne muscular dystrophy (76)
Earnings (40628)
Editorial (13)
Employer branding (2)
Employer resources (16)
Events (22166)
Executive appointments (103)
FDA (4763)
Fibrodysplasia Ossificans Progressiva (2)
Friedreich's ataxia (1)
Frontotemporal dementia (11)
Funding (224)
Gene editing (34)
Generative AI (5)
Gene therapy (127)
GLP-1 (306)
Government (936)
Grass and pollen (3)
Guidances (321)
Healthcare (4296)
HIV (18)
Huntington's disease (6)
IgA nephropathy (29)
Immunology and inflammation (80)
Immuno-oncology (12)
Indications (50)
Infectious disease (733)
Inflammatory bowel disease (46)
Inflation Reduction Act (2)
Influenza (26)
Intellectual property (49)
Interviews (48)
IPO (5890)
IRA (4)
Job creations (755)
Job search strategy (318)
JPM (6)
Kidney cancer (5)
Labor market (27)
Layoffs (144)
Legal (1213)
Liver cancer (20)
Longevity (3)
Lung cancer (208)
Lymphoma (131)
Machine learning (3)
Management (7)
Manufacturing (118)
MASH (56)
Medical device (3224)
Medtech (3236)
Mergers & acquisitions (3875)
Metabolic disorders (378)
Multiple sclerosis (57)
NASH (5)
Neurodegenerative disease (66)
Neuropsychiatric disorders (27)
Neuroscience (661)
NextGen: Class of 2026 (1362)
Non-profit (917)
Now hiring (7)
Obesity (154)
Opinion (28)
Ovarian cancer (59)
Pain (45)
Pancreatic cancer (58)
Parkinson's disease (60)
Partnered (6)
Patents (91)
Patient recruitment (85)
Peanut (24)
People (7291)
Pharmaceutical (9)
Pharmacy benefit managers (5)
Phase 1 (4613)
Phase 2 (7694)
Phase 3 (7312)
Pipeline (2359)
Policy (43)
Postmarket research (787)
Preclinical (1634)
Press Release (9)
Prostate cancer (86)
Psychedelics (8)
Radiopharmaceuticals (109)
Rare diseases (186)
Real estate (977)
Recruiting (6)
Regulatory (5551)
Reports (19)
Research institute (459)
Resumes & cover letters (41)
Rett syndrome (9)
RNA editing (5)
RSV (38)
Schizophrenia (37)
Series A (30)
Series B (28)
Service/supplier (1)
Sickle cell disease (22)
Special edition (15)
Spinal muscular atrophy (45)
Sponsored (8)
Startups (495)
Stomach cancer (4)
Supply chain (12)
Tariffs (18)
The Weekly (5)
Vaccines (295)
Venture capital (15)
Weight loss (107)
Women's health (17)
Worklife (1)
Date
Today (13)
Last 7 days (149)
Last 30 days (449)
Last 365 days (8575)
2026 (685)
2025 (8781)
2024 (9455)
2023 (10669)
2022 (12589)
2021 (13394)
2020 (12173)
2019 (10318)
2018 (7684)
2017 (10866)
2016 (5960)
2015 (7933)
2014 (5567)
2013 (3713)
2012 (4117)
2011 (4301)
2010 (4210)
Location
Africa (276)
Alabama (11)
Alaska (1)
Arizona (40)
Arkansas (2)
Asia (9547)
Australia (1422)
California (2877)
Canada (982)
China (328)
Colorado (166)
Connecticut (143)
Delaware (121)
Europe (24520)
Florida (361)
Georgia (116)
Idaho (9)
Illinois (200)
India (19)
Indiana (168)
Iowa (6)
Japan (152)
Kansas (39)
Kentucky (5)
Louisiana (11)
Maine (34)
Maryland (301)
Massachusetts (2073)
Michigan (87)
Minnesota (166)
Mississippi (4)
Missouri (30)
Montana (6)
Nebraska (3)
Nevada (46)
New Hampshire (20)
New Jersey (1022)
New Mexico (1)
New York (880)
North Carolina (416)
North Dakota (1)
Northern California (1459)
Ohio (52)
Oklahoma (1)
Oregon (3)
Pennsylvania (631)
Puerto Rico (5)
Rhode Island (2)
South America (370)
South Carolina (8)
Southern California (1153)
Tennessee (31)
Texas (394)
United States (10518)
Utah (76)
Virginia (53)
Washington D.C. (12)
Washington State (242)
Wisconsin (28)
157,127 Results for "17".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Deals
Roche Keeps the Deals Coming With up to $1.7B SangeneBio RNAi Pact
The alliance will add to Roche’s RNAi efforts, which include the hypertension candidate zilbesiran, partnered with Alnylam under a July 2023 agreement.
February 3, 2026
·
1 min read
·
Tristan Manalac
Press Releases
Krystal Biotech to Report Fourth Quarter and Full Year 2025 Financial Results on February 17, 2026
February 10, 2026
·
1 min read
Press Releases
4DMT Announces New Employment Inducement Grants - January 17, 2026
January 19, 2026
·
2 min read
Press Releases
Biofrontera Inc. Announces Record Preliminary Fourth Quarter 2025 Revenues between $17.0 Million and $17.5 Million, Representing Approximately 35% Year-Over-Year Growth
January 14, 2026
·
5 min read
Press Releases
NeoGenomics to Report Fourth Quarter and Full Year 2025 Financial Results on February 17, 2026
January 27, 2026
·
1 min read
Press Releases
Lantern Pharma to Present at the 7th Glioblastoma Drug Development Summit in Boston on February 17-19, 2026
February 11, 2026
·
5 min read
Press Releases
Esomeprazole Market to Reach USD 3.17 Billion by 2032 Driven by GERD Prevalence
January 13, 2026
·
1 min read
Press Releases
Ocular Therapeutix™ to Announce Topline Data for SOL-1 Phase 3 Superiority Trial in Wet AMD on Tuesday, February 17, 2026
February 15, 2026
·
2 min read
Press Releases
PeptiDream Announces Promising Pre-Clinical Results of Proprietary Oral IL-17A and IL-17F Dual Inhibitor with Biologic-Like Efficacy for the Treatment of Psoriasis
December 18, 2025
·
3 min read
Press Releases
Tiziana Life Sciences Announces Registered Direct Offering of up to approximately $17.6 Million
January 16, 2026
·
6 min read
1 of 15,713
Next
